Home Tags Cancer: Skin

Tag: Cancer: Skin

Chronic Adverse Effects From Anti-PD-1 Immunotherapies Common

About 43 percent of patients who receive anti-PD1 therapy for advanced melanoma have chronic immune-related adverse effects

Fecal Transplant May Counter Anti-PD-1 Resistance in Melanoma

FMT plus anti-PD-1 therapy may change gut microbiome and help overcome drug resistance in some patients with advanced melanoma

Biomarker May Predict Treatment Outcome in Advanced Melanoma

Changes in plasma levels of ctDNA associated with survival outcomes in BRAF V600 mutation-positive unresectable or metastatic melanoma

ICI Need Not Be Withheld in Those With Autoimmune Disease

Objective response rates to anti-CTL4, anti-PD-1, combination similar for advanced melanoma patients with, without AID

Acute AEs With Gadolinium-Based Contrast Agents Low in Cardiac MRI

Immune Checkpoint Inhibitor Therapy Tied to Cardiac Event Risk

Increased risks persist beyond six months for patients with lung cancer receiving PD1i and with malignant melanoma receiving CTLA-4i

UV Exposure Not Linked to Risk for Melanoma in Skin of Color

In 11 of 13 studies reviewed, no association observed between UV exposure, melanoma in skin of color

AI Model May Predict Immunotherapy Response in Melanoma

Histology slides, clinical data used to predict immune checkpoint inhibitor response in advanced melanoma

For patients with stage III melanoma with BRAF V600E or V600K mutations

Benefit of Adjuvant Dabrafenib + Trametinib Persists in Melanoma

Long-term benefit seen for relapse-free survival in stage III disease with BRAF V600E, V600K mutations
Postoperative follow-up telephone calls to patients after Mohs micrographic surgery do not improve patient satisfaction

Follow-up Calls After Mohs Surgery Do Not Boost Satisfaction

But calls made the evening of dermatology surgery can identify patients with active pain
There is no association between use of topical calcineurin inhibitors for the treatment of atopic dermatitis and an increased risk for skin cancer

Topical Calcineurin Inhibitors Not Tied to Skin Cancer

No increased risk seen with topical calcineurin versus topical corticosteroids in adults with dermatitis